Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Revue Medicale Suisse|May 17, 2024
[Male breast cancer: a lesser-known battle]Hinde Benchaa, Athina StravodimouAnticancer Research|July 3, 2019
A Systematic Review and Meta-analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-positive Metastatic Breast CancerAthina Stravodimou, Ioannis A VoutsadakisTranslational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|February 12, 2026
Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative reviewAthina Stravodimou, Ioannis A VoutsadakisAnticancer Research|February 28, 2023
Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes Besides <i>BRCA1</i> and <i>BRCA2</i> as Breast Cancer Biomarkers for PARP Inhibitors and Other DDR Targeting TherapiesIoannis A Voutsadakis, Athina StravodimouInternational Journal of Breast Cancer|July 19, 2013
Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancerAthina Stravodimou, Ioannis A VoutsadakisAnticancer Research|September 4, 2020
The Future of ER+/HER2- Metastatic Breast Cancer Therapy: Beyond PI3K InhibitorsAthina Stravodimou, Ioannis A VoutsadakisExpert Review of Anticancer Therapy|March 13, 2024
Neo-adjuvant therapies for ER positive/HER2 negative breast cancers: from chemotherapy to hormonal therapy, CDK inhibitors, and beyondAthina Stravodimou, Ioannis A VoutsadakisWorld Journal of Clinical Oncology|March 23, 2022
Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomasAthina Stravodimou, Ioannis A VoutsadakisISRN Oncology|July 10, 2014
Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution SeriesAthina Stravodimou, Khalil Zaman, Ioannis A VoutsadakisPPAR Research|October 11, 2012
Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancerAthina Stravodimou, Gianluigi Mazzoccoli, Ioannis A VoutsadakisPageof 4